Actively Recruiting
Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis
Led by CHU de Reims · Updated on 2026-05-06
62
Participants Needed
1
Research Sites
124 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a double-blind interventional superiority study evaluating the efficacy of suprascapular nerve block in addition to conventional therapies for adhesive capsulitis. Adhesive capsulitis is a pathology that results in reduced shoulder mobility due to retraction of the periarticular capsule. It may be primary or secondary to traumatic or neurological events, or associated with diabetes in particular. The usual treatment includes re-education sessions to improve joint amplitude and restore shoulder mobility. In persistent forms, intra-articular injection of cortisone is combined with distension of the capsule with a local anaesthetic under radiographic control. In some countries, subscapular nerve block (reversible anaesthesia) is used to improve pain. The combination of arthrodistension and subscapular nerve block has never been performed to accelerate the healing process. The aim of this study is to compare the performance of these two procedures together against the reference technique alone on time to improvement with the number of patients improved at one month according to the Constant score. This score is used to assess shoulder pain and function, with a significant improvement above eight points.
CONDITIONS
Official Title
Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient treated for adhesive capsulitis with loss of passive shoulder movement of more than 20° in external rotation or abduction compared to the other shoulder
- Patient over 18 years of age
- Patient covered by a social security scheme
- Presence of an accompanying person on the day of the procedure for the return trip
- Patient who has signed the consent form to participate in the study
You will not qualify if you...
- Patient protected by law
- Pregnant women
- Patient who has had shoulder surgery less than six months ago
- Patient unable to undergo rehabilitation within one month of surgery
- Allergy to anesthetic or iodinated contrast medium
- Neuro-orthopedic disorder that prevents clinical recovery
- Hemostasis disorder that contraindicates nerve block (including non-discontinuation of anticoagulants or congenital bleeding disorders)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu Reims
Reims, France, 51092
Actively Recruiting
Research Team
L
Lois BOLKO
CONTACT
J
Jean Hugues SALMON
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here